These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2717572)

  • 41. [The clinical significance of the sulfhydryl groups in the peripheral blood lymphocytes of patients with thyrotoxic goiter].
    Podil'chak MD; Terlets'ka LM; Vynnychenko BI
    Lik Sprava; 1992 Apr; (4):92-3. PubMed ID: 1441393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic thyroiditis with painful tender thyroid enlargement and transient thyrotoxicosis.
    Shigemasa C; Ueta Y; Mitani Y; Taniguchi S; Urabe K; Tanaka T; Yoshida A; Mashiba H
    J Clin Endocrinol Metab; 1990 Feb; 70(2):385-90. PubMed ID: 2405003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [T3-thyrotoxicosis: incidence, significance and correlation with iodine intake].
    Konrády A
    Orv Hetil; 2000 Feb; 141(7):337-40. PubMed ID: 10703222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dynamic thyroid function after the surgical treatment of patients with diffuse toxic goiter].
    Galkin RA; Popov AIu
    Probl Endokrinol (Mosk); 1988; 34(6):13-8. PubMed ID: 3148927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Environmental iodine intake affects the response to methimazole in patients with diffuse toxic goiter.
    Azizi F
    J Clin Endocrinol Metab; 1985 Aug; 61(2):374-7. PubMed ID: 3839244
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thyroid-stimulating immunoglobulins and the control of thyroid function.
    Clague R; Mukhtar ED; Pyle GA; Nutt J; Clark F; Scott M; Evered D; Smith BR; Hall R
    J Clin Endocrinol Metab; 1976 Sep; 43(3):550-6. PubMed ID: 821961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The correlation between protein-bound iodine and iodine extracted with butanol in the blood of health subjects and of patients with diffuse nontoxic sporadic goiter].
    Shliakhtina LG
    Probl Endokrinol Gormonoter; 1966; 12(5):3-5. PubMed ID: 4176990
    [No Abstract]   [Full Text] [Related]  

  • 48. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
    Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
    J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
    [No Abstract]   [Full Text] [Related]  

  • 49. [Diffuse toxic goiter associated with autoimmune thyroiditis].
    Natarov VV; Tsarikovskaia NG; Tkach FS; Grinchenko TS; Gorbenko VN
    Probl Endokrinol (Mosk); 1985; 31(4):13-6. PubMed ID: 3840258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ¹³¹I treatment of toxic nodular goiter under combined thyrostatic-thyromimetic medication is at low risk of late hypothyroidism.
    Paghera B; Panarotto MB; Maira G; Magri GC; Bertagna F; Bosio G; Rossini P; De Agostini A; Savelli G; Lucchini S; Giubbini R
    Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):341-7. PubMed ID: 20639819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK; Yoo WS; Kim DW; Chung HK
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyrotoxicosis in children: treatment and outcome.
    Jaruratanasirikul S; Leethanaporn K; Sriplung H
    J Med Assoc Thai; 2006 Jul; 89(7):967-73. PubMed ID: 16881428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin.
    Rapoport B; Greenspan FS; Filetti S; Pepitone M
    J Clin Endocrinol Metab; 1984 Feb; 58(2):332-8. PubMed ID: 6141176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of the therapy of thyrotoxicosis on the status of the reproductive system of girls with diffuse toxic goiter].
    Varlamova TM; Kerova AN
    Pediatriia; 1987; (7):69-71. PubMed ID: 3671011
    [No Abstract]   [Full Text] [Related]  

  • 55. [Thyroid tissue link of hemostasis in diffuse toxic and euthyroid goiter].
    Kirichuk VF
    Probl Endokrinol (Mosk); 1979; 25(3):27-31. PubMed ID: 582337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further studies on thyroid growth-stimulating immunoglobulins in euthyroid nonendemic goiter.
    van der Gaag RD; Drexhage HA; Wiersinga WM; Brown RS; Docter R; Bottazzo GF; Doniach D
    J Clin Endocrinol Metab; 1985 May; 60(5):972-9. PubMed ID: 2858493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Iodine excess and hyperthyroidism.
    Roti E; Uberti ED
    Thyroid; 2001 May; 11(5):493-500. PubMed ID: 11396708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Certain problems of pathogenesis of diffuse non-toxic sporadic goiter].
    Potin VV; Tarasova OV; Shliakhtina LG
    Probl Endokrinol (Mosk); 1974; 20(6):27-31. PubMed ID: 4141506
    [No Abstract]   [Full Text] [Related]  

  • 59. Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapy.
    Antonelli A; Ferrari SM; Corrado A; Ferrannini E; Fallahi P
    Thyroid; 2013 Nov; 23(11):1461-9. PubMed ID: 23721189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of lithium carbonate in the therapy of diffuse toxic goiter].
    Pimenov LT
    Probl Endokrinol (Mosk); 1982; 28(1):26-32. PubMed ID: 6801641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.